Oncotarget

Research Papers:

Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies

Xingshun Qi, Jianjun Li, Han Deng, Hongyu Li, Chunping Su and Xiaozhong Guo _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:45283-45301. https://doi.org/10.18632/oncotarget.9942

Metrics: PDF 1819 views  |   HTML 1788 views  |   ?  


Abstract

Xingshun Qi1,*,#, Jianjun Li2,*,#, Han Deng1, Hongyu Li1, Chunping Su3, Xiaozhong Guo1,#

1Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, Liaoning 110840, China

2Department of Radiotherapy, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China

3Library of Fourth Military Medical University, Xi’an, Shaanxi 710032 China

*These authors have contributed equally

#Joint senior authors

Correspondence to:

Xingshun Qi, email: xingshunqi@126.com

Jianjun Li, email: 13309883641@163.com

Xiaozhong Guo, email: guo_xiao_zhong@126.com

Keywords: hepatocellular carcinoma, inflammatory, neutrophil, lymphocyte, prognosis

Received: March 26, 2016     Accepted: May 16, 2016     Published: June 10, 2016

ABSTRACT

Background and aims: Neutrophil to lymphocyte ratio (NLR) is an inflammatory-based marker. A systematic review and meta-analysis was performed to explore the prognostic role of NLR in patients with hepatocellular carcinoma (HCC).

Results: Overall, 598 papers were identified, of which 90 papers including 20,475 HCC patients were finally included. Low baseline NLR was significantly associated with better overall survival (HR = 1.80, 95% CI: 1.59–2.04, p < 0.00001) and recurrence-free or disease-free survival (HR = 2.23, 95% CI: 1.80–2.76, p < 0.00001). Low post- treatment NLR was significantly associated with better overall survival (HR = 1.90, 95% CI: 1.22–2.94, p = 0.004). Decreased NLR was significantly associated with overall survival (HR = 2.23, 95%CI: 1.83–2.72, p < 0.00001) and recurrence-free or disease-free survival (HR = 2.23, 95% CI: 1.83–2.72, p < 0.00001). The findings from most of subgroup meta-analyses were consistent with those from the overall meta-analyses.

Materials and Methods: All relevant literatures were identified via PubMed, EMBASE, and Cochrane library databases. Hazard ratio (HR) with 95% confidence interval (95%CI) was calculated. Subgroup meta-analyses were performed according to the treatment options, NLR cut-off value ranges, and regions.

Conclusions: NLR should be a major prognostic factor for HCC patients. NLR might be further incorporated into the prognostic model of HCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 9942